Form 4 for MAZE Maze Therapeutics, Inc.
Accepted 2025-02-04 00:00:00 ET · period of report 2025-02-03 · accession 0000950170-25-013760 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2025-02-04 | 2025-02-03 | MAZE | Third Rock Ventures IV, L.P. | 10% | C - Cnv Deriv | $0.00 | +950.8K | 950.8K | New | $0 |
| D | 2025-02-04 | 2025-02-03 | MAZE | Third Rock Ventures IV, L.P. | 10% | C - Cnv Deriv | $0.00 | +5.76M | 6.07M | +1,852% | $0 |
| DM | 2025-02-04 | 2025-02-03 | MAZE | Third Rock Ventures IV, L.P. | 10% | C - Cnv Deriv | $0.00 | -55.56M | 0 | -100% | $0 |
| DI | 2025-02-04 | 2025-02-03 | MAZE | Third Rock Ventures IV, L.P. | 10% | C - Cnv Deriv | $0.00 | -9.17M | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-03 | C | A | 950,800 | $0.00 | 950,800 | I | — | — | |
| 2 | Common | Common Stock | 2025-02-03 | C | A | 5,762,788 | $0.00 | 6,073,958 | D See Footnotes | — | — | (F2) The shares are held directly by Third Rock Ventures IV, L.P. ("TRV IV"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. ("TRV GP IV"). The general partner of TRV GP IV is TRV GP IV, LLC ("TRV GP IV LLC"). Each of TRV GP IV, and TRV GP IV LLC, disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares. (F4) Each of Reporting Persons disclaims the existence of a Section 13(d) "group" as between the TRV IV related parties and the TRV V related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties. (F3) The shares are held directly by Third Rock Ventures V, L.P. ("TRV V"). The general partner of TRV V is Third Rock Ventures GP V, L.P. ("TRV GP V"). The general partner of TRV GP V is TRV GP V, LLC ("TRV GP V LLC"). Each of TRV GP V, and TRV GP V LLC, disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares. |
| 3 | Derivative | Series A Preferred Stock | 2025-02-03 | C | D | 45,833,334 | $0.00 | 0 | D See Footnotes | — · — to — | 4,754,002 Common Stock | (F2) The shares are held directly by Third Rock Ventures IV, L.P. ("TRV IV"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. ("TRV GP IV"). The general partner of TRV GP IV is TRV GP IV, LLC ("TRV GP IV LLC"). Each of TRV GP IV, and TRV GP IV LLC, disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares. (F4) Each of Reporting Persons disclaims the existence of a Section 13(d) "group" as between the TRV IV related parties and the TRV V related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties. (F3) The shares are held directly by Third Rock Ventures V, L.P. ("TRV V"). The general partner of TRV V is Third Rock Ventures GP V, L.P. ("TRV GP V"). The general partner of TRV GP V is TRV GP V, LLC ("TRV GP V LLC"). Each of TRV GP V, and TRV GP V LLC, disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares. (F1) Upon the closing of the Issuer's initial public offering, each share of Series A Preferred Stock and Series D-1 Preferred Stock (collectively, the "Preferred Stock") automatically converted into Common Stock on a one-for-0.1037 basis without payment of consideration. The Preferred Stock had no expiration date. |
| 4 | Derivative | Series A Preferred Stock | 2025-02-03 | C | D | 9,166,666 | $0.00 | 0 | I | — · — to — | 950,800 Common Stock | (F1) Upon the closing of the Issuer's initial public offering, each share of Series A Preferred Stock and Series D-1 Preferred Stock (collectively, the "Preferred Stock") automatically converted into Common Stock on a one-for-0.1037 basis without payment of consideration. The Preferred Stock had no expiration date. |
| 5 | Derivative | Series D-1 Preferred Stock | 2025-02-03 | C | D | 9,725,709 | $0.00 | 0 | D | — · — to — | 1,008,786 Common Stock | (F2) The shares are held directly by Third Rock Ventures IV, L.P. ("TRV IV"). The general partner of TRV IV is Third Rock Ventures GP IV, L.P. ("TRV GP IV"). The general partner of TRV GP IV is TRV GP IV, LLC ("TRV GP IV LLC"). Each of TRV GP IV, and TRV GP IV LLC, disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that it is the beneficial owner of such shares. (F4) Each of Reporting Persons disclaims the existence of a Section 13(d) "group" as between the TRV IV related parties and the TRV V related parties and this report shall not be deemed an admission that any of such parties is or may be part of such a group with any of the other parties. (F1) Upon the closing of the Issuer's initial public offering, each share of Series A Preferred Stock and Series D-1 Preferred Stock (collectively, the "Preferred Stock") automatically converted into Common Stock on a one-for-0.1037 basis without payment of consideration. The Preferred Stock had no expiration date. |